DataLink’s Evoke360 Population Health Solution Receives NCQA Health Plan Measure Certification℠ for HEDIS® Measures 2020

Formerly known as CareBook, Evoke360 meets rigorous requirements

TAMPA, Fla.–(BUSINESS WIRE)–DataLink Software (DataLink), a leading solution to enhance interoperability, reduce costs, improve quality scores and ensure risk adjustment accuracy, has achieved the National Committee for Quality Assurance (NCQA) certification for the Healthcare Effectiveness Data and Information Set (HEDIS®) Health Plan 2020 for all measures. NCQA’s HEDIS Health Plan Measure Certification℠ is precise, automated testing that verifies compliance with HEDIS and further validates the Evoke360 population health solution, formerly CareBook, to offer real-time data aggregation that assists in quality improvement initiatives.

“Our participation in NCQA’s Health Plan Measure Certification program ensures the highest level of quality and demonstrates to health plans the integrity of our solution,” says Kevin Steele, chief executive officer, DataLink. “We provide a best-in-class technology approach that minimizes up-front investment while delivering premier analytics and value-based intelligence to reduce costs, and improve quality and care delivery for patients, providers and health plans.”

Evoke360 is a clinical, operational and social determinant data platform built from a mindset of providing a holistic view of the patient with true data transparency, comprehensive insights related to chronic conditions, pharmacy, laboratory tests, gaps in care, social needs, quality and risk adjustment metrics. Evoke360 optimizes quality, reduces administrative burden, enables value-based care and enhances financial performance and communication with visibility into all health plan operations in one point-of-care solution.

Over 90 percent of America’s health plans use the NCQA certification for HEDIS measures to evaluate and improve overall performance.

Steele adds, “This HEDIS certification demonstrates DataLink’s commitment to empowering better health by enabling payers, providers and care partners with real-time data aggregation, EHR connectivity and dynamic dashboards and reporting. Our solution reduces costs, improves quality scores and simplifies healthcare navigation. This serves as testimony to our ability to support care delivery, quality improvement, efficient operations and network performance.”

About DataLink Software

DataLink Software (DataLink) is a healthcare technology company that empowers better health by enabling payers, providers and care partners with real-time data aggregation, EHR connectivity and dynamic dashboards and reporting. DataLink’s intelligent, data-driven solutions drive value by reducing the cost of care, improving quality scores, ensuring risk adjustment accuracy and simplifying healthcare navigation. Visit https://datalinksoftware.com/

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

The NCQA HEDIS Health Plan Certified Measures
seal is a service mark of NCQA.

Contacts

Media:
Nicole Dufour

CPR Communications

ndufour@cpronline.com
201.641.1911 x 54

Naeema Long

DataLink Software

naeema.long@datalinksoftware.com
813-903-1091

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

5 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

8 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

8 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

8 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

8 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

8 hours ago